ResearcherGeisinger Health SystemActive in the last 2 years

Mark J Wojtowicz

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0003-2892-9404; OpenAlex author ID A5065865860.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics. Last author DOI 10.1016/j.jpainsymman.2024.10.004 ↗
Is Weight Loss During Chemotherapy for Pancreatic Cancer Prognostic? Last author DOI 10.1177/10499091221123049 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Mellar P. Davis · 2 shared papers, 2023–2025
- Paper Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics. DOI 10.1016/j.jpainsymman.2024.10.004 ↗
- Paper Is Weight Loss During Chemotherapy for Pancreatic Cancer Prognostic? DOI 10.1177/10499091221123049 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.